Pune (Maharashtra) [India]January 21 (ANI): As many as 10 tenders were rushed to the Serum Institute of India (SII) in Pune, Maharashtra on Thursday, where millions of doses of COVID-19 vaccine are being produced. According to officials, a fire has broken out at the gate of Terminal 1 and the fire continues to rage on the fourth and fifth floors of the SEZ3 building inside Terminal Gate 1. The site where the fire broke out, is a building under construction at the SII. The vaccine and the vaccine manufacturing facility are safe.
Sources told ANI: “At the Manjari plant a fire occurred at the Serum Institute of India. It will not affect Covidshield vaccine production. ”However, SII has not yet commented on the fire operations.
It may be noted that the country’s drug regulator had granted limited permission for emergency use to SII’s Covishield vaccine in India. Millions of vaccine doses are produced by the Serum Institute in technical collaboration with the University of Oxford / Astra Zeneca. It is relevant to note that the COVISHIELD vaccine (SII-ChAdOx1 nCoV-19) contains the replication-deficient simian adenovirus vector ChAdOx1, containing SARS-CoV-2 structural surface glycoprotein (Spike protein) antigens. (ANI)
(This story has not been edited by Devdiscourse staff and is automatically generated from a syndicated feed.)
- On Thursday, up to 10 firefighting contests were taken to the Serum Institute of India (SII) in Pune, Maharashtra, where millions of doses of the COVID-19 vaccine are produced.
- A fire breaks out at the Serum Institute in Pune, 10 tenders rushed to locate